M-A | Safety of sotagliflozin in diabetes mellitus type 1 and type 2. 19 Oct, 2022 | 14:12h | UTC The safety of sotagliflozin in the therapy of diabetes mellitus type 1 and type 2: A meta-analysis of randomized trials – Frontiers in Endocrinology
Open access
Open access